Cargando…
Demethylation of the TSDR Is a Marker of Squamous Cell Carcinoma in Transplant Recipients
Malignancy is an important cause of death in transplant recipients. Cutaneous squamous cell carcinoma (cSCC) causes significant morbidity and mortality as 30% of transplant recipients will develop cSCC within 10 years of transplantation. Previously we have shown that high numbers of regulatory T cel...
Autores principales: | Sherston, S N, Vogt, K, Schlickeiser, S, Sawitzki, B, Harden, P N, Wood, K J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4497351/ https://www.ncbi.nlm.nih.gov/pubmed/25250867 http://dx.doi.org/10.1111/ajt.12899 |
Ejemplares similares
-
CD45RA Distinguishes CD4+CD25+CD127−/low TSDR Demethylated Regulatory T Cell Subpopulations With Differential Stability and Susceptibility to Tacrolimus-Mediated Inhibition of Suppression
por: Arroyo Hornero, Rebeca, et al.
Publicado: (2017) -
Optimal management of young adult transplant recipients: the role of integrated multidisciplinary care and peer support
por: Harden, Paul Neil, et al.
Publicado: (2013) -
Molecular Markers Distinguishing T Cell Subtypes With TSDR Strand-Bias Methylation
por: Minskaia, Ekaterina, et al.
Publicado: (2018) -
Higher FOXP3-TSDR demethylation rates in adjacent normal tissues in patients with colon cancer were associated with worse survival
por: Zhuo, Changhua, et al.
Publicado: (2014) -
STAT5 and TET2 Cooperate to Regulate FOXP3-TSDR Demethylation in CD4(+) T Cells of Patients with Colorectal Cancer
por: Ma, Hulin, et al.
Publicado: (2018)